HF 701 (LSB 1957HV (1) 91)

HOUSE FILE 701

BY  COMMITTEE ON HEALTH AND HUMAN SERVICES

(SUCCESSOR TO HSB 209)

A BILL FOR

An Act relating to a review of anti-obesity medications by the department of health and human services for purposes of the medical assistance program.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:

    Section 1.  ANTI-OBESITY MEDICATION REVIEW AND REPORT.  For purposes of the medical assistance program under chapter 249A, the department of health and human services shall review anti-obesity medications for effectiveness, the impact on comorbidities, the potential for cost savings due to deferred medical procedures and reduced medications related to comorbidity, recommended eligibility requirements, and any other criteria the department deems relevant. The department shall submit a report to the general assembly by December 1, 2025, with the department’s findings and proposed eligibility requirements.
EXPLANATION
The inclusion of this explanation does not constitute agreement with
the explanation’s substance by the members of the general assembly.
   This bill relates to the department of health and human services (HHS) review of anti-obesity medication for purposes of the medical assistance program (Medicaid).
   The bill requires HHS to review anti-obesity medications for effectiveness, comorbidities, cost savings, and eligibility requirements as described in the bill. HHS shall submit a report to the general assembly by December 1, 2025, containing HHS’s findings and proposed eligibility requirements.